Hilltop Holdings Inc. Surface Oncology, Inc. Transaction History

Hilltop Holdings Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$5.16 - $7.98 $52,116 - $80,598	-10,100 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.25 - $13.82 $73,225 - $139,582	10,100 New	10,100 $79,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Hilltop Holdings Inc., based on Form 13F filings with the SEC.

Stay updated on Hilltop Holdings Inc. with notifications on news.